Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
May 7, 2025Frontiers in PharmacologyOpen Access

Editorial: Identification of effective biomarkers for diagnosis and treatment of chronic kidney disease: integrating bioinformatics and pharmacological approaches

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Despite the importance of early detection and management of CKD, there is a lack of reliable diagnostic biomarkers and effective therapeutic targets.

Design

Editorial

Authors

SSSwayam Prakash SrivastavaKKKeizo Kanasaki

Discussion

Loading...

Member takes

Overview

May inform early CKD strategies in select patients; leaves open reliable biomarkers and targets for confirmatory trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Srivastava et al. (2025) studied this question.

synapsesocial.com/papers/6a911ea12239ecaee3361659https://doi.org/10.3389/fphar.2025.1606173
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen2016 · 42 citations
  2. 2Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms2023 · 9 citations
  3. 3N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition2014 · 87 citations
  4. 4Prevalence of and risk factors for chronic kidney disease of unknown aetiology in India: secondary data analysis of three population-based cross-sectional studies2019 · 70 citations
  5. 5Inhibition of ROCK2 alleviates renal fibrosis and the metabolic disorders in the proximal tubular epithelial cells2020 · 29 citations